Author:
Panzeri Elena,Citterio Andrea,Martinuzzi Andrea,Ancona Vera,Martini Eleonora,Bassi Maria Teresa
Abstract
Defects in FARS2 are associated with either epileptic phenotypes or a spastic paraplegia subtype known as SPG77. Here, we describe an 8-year-old patient with severe and complicated spastic paraplegia, carrying a missense variant (p.Pro361Leu) and a novel intragenic deletion in FARS2. Of note, the disease is unexpectedly progressing rapidly and in a biphasic way differently from the previously reported cases. Our study provides the first detailed molecular characterization of a FARS2 deletion and its underlying molecular mechanism, and demonstrates the need for combining different tools to improve the diagnostic rate.
Subject
Genetics (clinical),Genetics,Molecular Medicine
Reference16 articles.
1. FARS2 deficiency; new cases, review of clinical, biochemical, and molecular spectra, and variants interpretation based on structural, functional, and evolutionary significance;Almannai;Mol. Genet. Metab.,2018
2. Novel FARS2 variants in patients with early onset encephalopathy with or without epilepsy associated with long survival;Barcia;Eur. J. Hum. Genet.,2021
3. FARS2 deficiency in Drosophila reveals the developmental delay and seizure manifested by aberrant mitochondrial tRNA metabolism;Fan;Nucleic Acids Res.,2021
4. FARS2 causing complex hereditary spastic paraplegia with dysphonia: Expanding the disease spectrum;Forman;J. Child. Neurol.,2019
5. FARS2 mutations: More than two phenotypes? A case report;Hotait;Front. Genet.,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献